Get started
Author

Rebecca Umayam

Efficacy from the phase 1 study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with head and neck squamous cell carcinoma.
2024 · Lydia D. Chow, Robert Hsu, et al. · Journal of Clinical Oncology · 1
Outcomes of Patients With Solid Tumor Treated on Phase I Clinical Trials Within a Comprehensive Cancer Center's Private and Safety-Net Hospitals
2025 · Jacob Stephen Thomas, Gage Guerra, et al. · JCO Oncology Practice
Breaking barriers for cancer clinical trials: A multi-tiered interventional approach to boost racial and ethnic minority participation in early-phase studies.
2024 · Hadi Erfani, Jacob Stephen Thomas, et al. · Journal of Clinical Oncology
PDF
Abstract 996: Predicting early mortality in a large ethnically diverse phase I clinical trial program
2024 · Hadi Erfani, Sabrina Woll, et al. · Cancer Research
Abstract 5532: Increasing racial and ethnic diversity of phase 1 solid tumor clinical trials through enrollment at a safety net hospital
2023 · Varun Roy, Esther Lee, et al. · Cancer Research
Assessing somatic and germline variants in cancer patients.
2021 · Charité Ricker, Erika Amundson, et al. · Journal of Clinical Oncology
Works count: 6
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type